Menopause Treatment Industry Analysis in India
The pharmaceutical sector is growing at a rapid pace, and one of the major contributors is the gynecological segment. Women’s health has always been neglected, but as severe health issues are arising, they are looking for affordable and effective treatments. At every stage, women deal with various hormonal changes in their bodies from puberty to reproductive age, and from menstrual age to menopause.
Hence, they need the best treatments to take care of themselves. But most women are not aware of how much these changes can affect them. Also, due to a poor lifestyle, they face challenges in pregnancy and at the time of menopause. That’s why many leading companies like Adorefem are creating a global buzz for these health issues.
Adorefem is an ISO-WHO certified company that manufactures its products for the gynae and IVF/infertility range. Over the years, we have set a benchmark in the industry and become the top choice of many manufacturers and entrepreneurs seeking business opportunities in this segment.
In this blog, Adorefem will throw light on the menopause treatment industry analysis in India and how it has emerged as a leading gynae pharma company in India. If you want to collaborate with us, contact us today!
Menopause Treatment Industry Analysis in India
The menopausal treatment industry is driven by manufacturing effective products to cure symptoms such as vaginal dryness, hot flushes, and bone loss. But, there is a high demand for hormone therapies as they are considered safe and highly effective by women. Additionally, a study by the Journal of Mid-Life Health showed that Indian women face menopause at 4-5 years younger than women in Western countries.
Here are quick stats to help you understand the growth of the menstrual treatment industry in India. Also, these insights are based on the research done by Future Market Insights:
| Metric | Value / Detail |
|---|---|
| Industry Value in 2025 | $83.1 Billion |
| Industry Value by 2035 | $157.6 Billion |
| Forecast CAGR (2025-2035) | 6.6% |
| Leading Segment | Hormone Therapy |
| Market Segments | Hormonal (29.6%) Non-Hormonal (43.5%) Dietary Supplements (26.9%) |
| Major Growth Regions across the Globe | North America, Asia-Pacific, Europe |
| Key Players | Intas Pharmaceuticals Ltd, Zydus Cadila, Torrent Pharmaceuticals Pvt Ltd, Emcure Pharmaceuticals, Koye Pharmaceuticals Pvt Ltd, etc. |
We hope that after going through this list, you are now aware of the market trends. Adding to this list, the Indian menopausal treatment industry grew at a CAGR of 5.8% from 2020 to 2025. If we talk about numbers, the menopausal industry was valued at $60.4 billion in 2020 and has now reached $83.1 billion in 2025. Hence, it is safe to say that it is the right time to invest in this segment. Furthermore, this industry is dominated by prescription-based medicines as these therapies require supervision from a medical expert.
Quality Assured Menopause Treatments Offered by Adorefem
Adorefem has curated more than 250 products to date and aims to add 50 products each year, catering to the rising demand for various medicines across India. We are encouraging manufacturers, distributors, and sellers to associate with us and avail budget-friendly partnership deals. With the right support and product range, you can surely achieve heights.
Our menopausal treatments are available in a wide range of forms, including tablets, capsules, syrups, sheets, and many more. Every product is formulated with handpicked raw materials that are clinically tested and have top-notch quality. Additionally, the QA team monitors each step of manufacturing. Hence, our products are packed with precision and reliability.
Here are some of the best formulations offered by us to treat menopausal symptoms. Also, these are endorsed by doctors from leading hospitals and healthcare institutions.
| Horny Goat Weed Ext. 500 mg, Maca Ext. 75 mg | Natural Micronised Progesterone 200 mg |
| Natural Micronised Progesterone 300 mg (Sustained Release Tab) | Natural Micronised Progesterone 400 mg |
| Natural Micronised Progesterone 8% gel in pre-filled applicator | Medroxyprogesterone 10 mg |
| Norethisterone 10 mg (Control Release Tab) | Estradiol Valerate Tablets 2 mg |
| Ethinyloestradiol 0.05 mg + Levonorgestrel 0.25 mg | Mifepristone 25 mg |
Best Gynae Pharma Company in India | Adorefem
We have expertise of more than 16 years in the pharma sector. Our cGMP-compliant manufacturing unit is what helps our products stand out in the market. Whether you are a newcomer, Adorefem will provide you with comprehensive training so that you stay ahead of the times.
Also, Adorefem gives the freedom of flexibility, such that you do not have any fixed number of targets and can run the franchise according to you. With our low investment plans, you do not have to face any kind of risk. Furthermore, by associating with us, you get a lot of advantages, including:
- Exclusive Monopoly Rights
- PAN India PCD pharma franchisee
- Timely Delivery in both urban and rural areas
- Diverse Network among Healthcare Professionals
- DCGI Approved Products
- Free Marketing & Promotional Support
- 24/7 Customer Support
So, what are you waiting for? Step into the world of unlimited business opportunities and contribute to the gynaecological market with a wide range of products offered by Adorefem.
Conclusion
We hope that after reading the above blog, you are now aware of the trusted gynae pharma company, Adorefem and how choosing the menopause product segment can uplift your presence in the industry. So, do not wait and book your consultation with us by reaching out at: +91-9877530744 || adorefemmailbox@gmail.com.